LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Alternative Methods Compared for Urine Culture Collection and Transport

By LabMedica International staff writers
Posted on 24 Aug 2016
Print article
Image: The UriSwab is an advanced system for collection, transport and preservation of urine specimens from the collection site to the testing laboratory (Photo courtesy of Copan).
Image: The UriSwab is an advanced system for collection, transport and preservation of urine specimens from the collection site to the testing laboratory (Photo courtesy of Copan).
The ability to isolate and identify causative agents of urinary tract infections relies primarily on the quality of the urine sample that is submitted to the microbiology laboratory.

Quantitation, identification and antimicrobial susceptibility testing is predicated on initial appropriate collection, ensuring that transport is performed in such a way as to preserve the right pathogen at the correct concentration, and third, that what is assumed to be the pathogen is actually causing an infection.

Microbiologists at the University of Alberta Hospital (Edmonton, AB, Canada) have reported a composite of several investigations comparing collection and transport on urine culture paddles, with a preservative urine sponge and a comparison of the urine sponge with a preservative transport tube as methods of preservation of urinary pathogens. Aside from the bedside issues of collection of mid-stream urines, samples from catheterized patients, and infants, there are concerns for transport of the sample to the laboratory to avoid overgrowth (or loss) of the causative organism.

The scientists used two devices as method of transport; the Becton Dickinson Urine Vacutainer, sometimes called a “Grey-Vac” (BD, Towson, MD, USA) and the Copan Uriswab (Copan Innovations, Brescia, Italy). In the Grey-Vac, urine is poured or transferred into the tube that contains a preservative pill and urine volume must reach the line on the tube (approximately 4 mL). In the Uriswab method, preservative is impregnated into the sponge, and the sponge is either dipped into the urine to saturate the sponge, or the patient may urinate directly onto the sponge. The Uriswab sponge holds approximately 1.5 mL. For collection of urine on the culture paddle, urine is collected into a sterile container. Morphotypes were quantitated and identification of uro-pathogens was made using either Vitek 2 (bioMérieux, Marcy-l'Étoile, France) GNI or GPI cards or with other validated non-automated methods.

The scientists reported that there were 25 more potential pathogen isolates recovered from the Uriswab than the culture paddle. Particularly for Escherichia coli, 10 additional isolates were identified from Uriswab, and there were no β-hemolytic streptococci recovered from the culture paddle. There were no significant differences in the number of different species recovered from both transport devices. An additional three E. coli were recovered at significant concentrations from Uriswab that were not observed in the Grey-Vac portion of the same urine sample.

The authors concluded that the isolation of urinary pathogens from sites both remote and close to the testing laboratory was enhanced by collection on the Uriswab compared both to culture paddle cultures and to the Grey-Vac preservative transport device. Costs for the culture paddle method become greater than either the Uriswab or the Grey-Vac because of the number of mixed cultures on the dip slides that need to be sub-cultured before determining if the isolates are significant to the infectious process. The study was published in the August 2016 issue of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:
University of Alberta Hospital
BD
Copan Innovations
bioMérieux
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
High Performance Centrifuge
CO336/336R
New
Multi-Function Pipetting Platform
apricot PP5

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.